Evidence map›Paper›PMID 37631057›Full record

ArticlePharmaceuticals (Basel, Switzerland)2023

The Importance of Uncertainty Analysis and Traceable Measurements in Routine Quantitative

Marco D'Arienzo, Emilio Mezzenga, Amedeo Capotosti, Oreste Bagni, Luca Filippi, Marco Capogni, Luca Indovina, Anna Sarnelli

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marco D'ArienzoMedical Physics Section, ASL Roma 6, Borgo Garibaldi 12, 00041 Rome, Italy.
Emilio MezzengaMedical Physics Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", 47014 Meldola, Italy.ORCID 0000-0002-0150-7757
Amedeo CapotostiFondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Roma, Italy.ORCID 0000-0002-3537-3187
Oreste BagniNuclear Medicine Department, Santa Maria Goretti Hospital, 04100 Latina, Italy.
Luca FilippiNuclear Medicine Department, Santa Maria Goretti Hospital, 04100 Latina, Italy.ORCID 0000-0003-4423-5496
Marco CapogniENEA, Italian National Institute of Ionizing Radiation Metrology, Via Anguillarese 301, 00123 Rome, Italy.ORCID 0000-0002-6206-1699
Luca IndovinaFondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Roma, Italy.ORCID 0000-0001-8073-9005
Anna SarnelliMedical Physics Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", 47014 Meldola, Italy.ORCID 0000-0001-5986-3845

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Molecular Radiation Therapy (MRT) is a valid therapeutic option for a wide range of malignancies, such as neuroendocrine tumors and liver cancers. In its practice, it is generally acknowledged that there is a need to evaluate the influence of different factors affecting the accuracy of dose estimates and to define the actions necessary to maintain treatment uncertainties at acceptable levels. The present study addresses the problem of uncertainty propagation in

Indexed as

90YdosimetryMRTmulticenterPETquantitative accuracyradionuclide therapyscanneruncertainty analysis

Identifiers

PMID37631057
PMCPMC10459699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.